Esperion Hopes CVOT Will Help Drive Nexletol/Nexlizet’s Market Uptake

 
• By Alaric DeArment
  
Esperion announced topline results from the CLEAR Outcomes trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D